Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma
Clinical trial NCT04589832 · TERMINATED
Trial details
- NCT number
- NCT04589832
- Sponsor
- Arkadiusz Z. Dudek, MD
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2022-03-22
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.